Founded in 1890 as the first manufacturer of electric fans in North America, Emerson Electric has become a leading industrial automation player through the acquisition of established brands... Show more
Emerson Electric stands as a global leader in automation solutions, with a sharpened focus on high-growth areas like industrial software, process control, and measurement technologies following strategic divestitures of non-core assets. The company derives significant revenue from its Automation Solutions segment, which includes valves, instrumentation, and software for industries such as oil & gas, chemicals, and power generation. Competitive advantages include a robust installed base generating recurring software revenue, strategic acquisitions enhancing its digital transformation offerings, and a global footprint supporting expansion in emerging markets. In the medium term, Emerson's pivot toward AI-enabled automation and electrification positions it favorably against peers like Rockwell Automation and Siemens, amid industry shifts toward lifecycle services and sustainability.
The Q2 2026 earnings release on May 5, 2026, after market close, represents the nearest catalyst, with analysts projecting adjusted EPS of $1.50-$1.55 and revenue around $4.60 billion. Strong performance in intelligent devices or software could prompt guidance upgrades, echoing recent fiscal 2026 adjusted EPS outlook raises to $6.40-$6.55. Other developments include potential partnerships in data center resilience and power sectors, as well as analyst revisions—recent adjustments like Wolfe Research's price target trim to $169 while maintaining Outperform reflect balanced optimism. Consensus ratings distribution (1 Sell, 10 Hold, 12 Buy from 23 analysts) and upward-trending price targets signal improving sentiment, particularly if capex cycles accelerate.
Emerson's trajectory hinges on industrial capex cycles, with tailwinds from rising investments in automation driven by AI adoption, data center expansion, and energy transition. Lower interest rates would ease funding for customer projects in process industries, while persistent inflation could pressure margins. Geopolitical tensions may disrupt supply chains for commodities like metals, but electrification trends in renewables and EVs bolster demand for Emerson's control systems. The regulatory push for sustainability aligns with the company's software for efficient operations, though broader economic slowdowns remain a headwind to discretionary spending.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that assists traders in identifying whether a stock, ETF, or other asset might trend bullish, bearish, or sideways over the next week or month. By analyzing vast datasets, it helps users detect emerging trends, potential breakouts or reversals, and provides predictions across thousands of tradable instruments. The engine features searchable prediction categories, historical performance context, and customizable alerts to enhance decision-making. Traders can explore its insights to stay ahead of market shifts—visit the Trend Prediction Engine for real-time analysis.
Looking to 2026 and beyond, Emerson targets sustained EPS growth toward $7.14 for fiscal 2027, supported by 5-6% organic revenue expansion and margin gains from software mix. Key themes include market penetration in high-growth verticals like life sciences and data centers, cost efficiencies via digital tools, and disciplined capital allocation prioritizing buybacks and dividends. Competitive threats from software disruptors loom, but Emerson's service-oriented model offers resilience. Regulatory developments in energy efficiency could accelerate adoption, while analyst expectations for price targets averaging $164-$167 reflect confidence in structural drivers like automation secular growth.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a developer of process controls systems, valves and analytical instruments
Industry IndustrialMachinery
A.I.dvisor indicates that over the last year, EMR has been closely correlated with ROK. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if EMR jumps, then ROK could also see price increases.
| Ticker / NAME | Correlation To EMR | 1D Price Change % |
|---|---|---|
| EMR | 100% | -2.54% |
| EMR (8 stocks) | 80% Closely correlated | -2.17% |
| Producer Manufacturing (352 stocks) | -1% Poorly correlated | -0.81% |
Be on the lookout for a price bounce soon.
The 10-day moving average for EMR crossed bullishly above the 50-day moving average on June 01, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in of 333 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 275 cases where EMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on June 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EMR as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for EMR turned negative on June 25, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
EMR moved below its 50-day moving average on July 01, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
EMR broke above its upper Bollinger Band on June 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.144) is normal, around the industry mean (7.131). P/E Ratio (34.771) is within average values for comparable stocks, (55.703). Projected Growth (PEG Ratio) (2.093) is also within normal values, averaging (2.114). Dividend Yield (0.015) settles around the average of (0.020) among similar stocks. P/S Ratio (4.627) is also within normal values, averaging (139.646).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EMR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.